Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Clinical trial NCT00893425 · COMPLETED

Trial details

NCT number: NCT00893425
Sponsor: Gulhane School of Medicine
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Proteinuria Diabetic Nephropathy Chronic Kidney Disease

Start date: 2008-01-01
Primary completion: 2009-03-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.